Drug Profile
NP 77A
Latest Information Update: 31 Jul 1998
Price :
$50
*
At a glance
- Originator Choongwae Pharma Corporation
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 31 Jul 1998 No-Development-Reported for Hepatitis B in South Korea (Unknown route)
- 18 Nov 1996 New profile
- 18 Nov 1996 Preclinical development for Hepatitis B in South Korea (Unknown route)